uploads/2016/06/dental-and-healthcare-consumables-1.png

Exploring XRAY’s Dental and Healthcare Consumables Businesses

By

Updated

Dental and healthcare consumables segment overview

Dentsply Sirona’s (XRAY) consumables products segment is the company’s leading segment, which is responsible for the manufacture, distribution, and sale of dental products, including restoratives, endodontics, prosthetics, instruments, preventive instruments, and medical device consumables.

The segment’s sales represented ~53% of the company’s total sales in 2015.

Article continues below advertisement

1Q16 performance

In 1Q16, Dentsply Sirona’s dental and healthcare consumables segment registered net sales of ~$489 million, representing constant currency sales growth of ~3.9%. The segment’s internal sales growth was ~4.5%. Its constant currency sales growth was ~2.2%, and its internal sales growth was ~2.8% in 1Q15.

All geographic regions reported equally strong revenue growth in the consumables products segment. The segment’s 1Q16 sales growth was driven by the consolidation of Dentsply’s and Sirona Medical’s businesses. A net acquisition benefit of ~0.7% contributed to the segment’s sales growth, whereas discontinued products unfavorably impacted its sales growth by ~1.2%. The strong US dollar also negatively impacted the segment’s sales growth by around 2.8%.

Key products

Dentsply Sirona has a leading portfolio of dental and healthcare consumables. Some of its key products include the recently introduced tooth-colored Celtra Duo ceramic block, the well-established EndoChoice platform solutions, the RINN product portfolio in preventive products, the Captivate by Nupro Whitening System, the Nupro Prophylaxis Paste, the Purevac Evacuation Cleaner, the Resurge Instrument Cleaner, and specialty drills.

Some of Dentsply Sirona’s US competitors include Zimmer Biomet Holdings (ZBH), Integra Lifesciences Holdings (IART), and Align Technology (ALGN). Dentsply Sirona accounts for ~0.08% of the total holdings of the iShares Core S&P 500 ETF (IVV).

Advertisement

More From Market Realist